Odd Lot Index

CHINA BIOPHARMACEUTICALS HOLDINGS INC

Terms unclear

Unclear — read the filing yourself
No closing date could be read from these filings. Nothing has been filed for this offer in over six months, so it is treated as closed — a tender offer cannot run that long. Check the filings below if you think otherwise.
StatusClosed (assumed)
Closing datecould not be read; last filing 2009-07-15
How it is pricedFixed price
Odd-lot thresholdFewer than 100 shares
Must tender everything you holdNot stated
Must tick the odd-lot box on the formNot stated
Price offeredUSD $1.75 per share
Most an odd-lot tender could be$173.25

Where each of these comes from

Every line above was read out of the filing. Here is the wording it was read from, so you can check it.

listed = True...d • the adjournment of the special meeting, if necessary, to solicit additional proxies, in the event that there are not sufficient votes at the time of the special meeting to approve any of the proposals submitted at the special meeting. NeoStem Common Stock is listed on the NYSE Amex under the trading symbol “NBS,” and NeoStem Common Stock closed at $1.92 per share on July 10, 2009. CBH Common Stock is quoted on the Over-the-Counter Bulletin Board under the symbol “CHBP.OB,” and CBH Common Stock closed at $0.23 per share on July 10, 2009. This joint proxy statement/prospectus provides you with detailed informati...
mechanism = FIXED...r of CBH, and Ding Weihua, a director of CBH), purchased 400,000 units for an aggregate consideration of $500,000, each unit comprised of one share of NeoStem Common Stock and one redeemable five-year warrant to purchase one share of NeoStem Common Stock at a purchase price of $1.75 per share, at a per-unit price of $1.25. In connection with Fullbright’s purchase of the units, EET borrowed $500,000 from RimAsia, and the units acquired by Fullbright were pledged to RimAsia as collateral therefor. Further, in the June/July 2009 private placement (as defined and described below), Fullbright acquired 64,000 shares of NeoStem Seri...
price = USD 1.75...gregate consideration of $500,000, each unit comprised of one share of NeoStem Common Stock and one redeemable five-year warrant to purchase one share of NeoStem Common Stock at a purchase price of $1.75 per share, at a per-unit price of $1.25. In connection with Fullbright’s purchase of the units, EET borrowed $500,000 from RimAsia, and the units acquired by Fullbright were pledged to RimAsia as collateral therefor. Further, in...
threshold = 100...be rounded up to the next whole share of NeoStem Common Stock. As a result, stockholders will not receive cash for fractional shares. Miscellaneous In the event the reverse stock split is effected, it will result in an increased number of stockholders owning “odd lots” of fewer than 100 shares of NeoStem Common Stock after the reverse split. The per share costs, including brokerage commissions, of transactions in odd lots, are generally higher than the costs of transactions in “round lots” of multiples of 100 shares. Procedure for Effecting Reverse Stock Split and Exchange of Stock Certificates If NeoStem’s stockholders approv...
txn_type = CONSOLIDATION...ed Stock into 12,932,510 shares of NeoStem Common Stock, together with the elimination of certain restrictions regarding certain warrant exercises and stock conversions; • an amendment to NeoStem’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of NeoStem Common Stock at a ratio within the range of 1:2 to 1:5, as determined by the NeoStem Board of Directors, solely in the event it is deemed by the NeoStem Board of Directors necessary to maintain its listing with the NYSE Amex or to list NeoStem Common Stock on any other exchange; • an amendment to the NeoStem, Inc. 2009 Equity...

The filings

FiledFormRoleOn EDGAR
2009-07-15SC TO-Toriginal (governing)View